# Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry

> **NCT02223637** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 93 (actual)

## Conditions studied

- Meningococcal Disease
- Pregnancy
- Infections, Meningococcal

## Interventions

- **BIOLOGICAL:** Meningococcal quadrivalent CRM-197 conjugate vaccine

## Key facts

- **NCT ID:** NCT02223637
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09-30
- **Primary completion:** 2017-12-08
- **Final completion:** 2017-12-08
- **Target enrollment:** 93 (ACTUAL)
- **Last updated:** 2019-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02223637

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02223637, "Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02223637. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*